34 results match your criteria: "Imperial College London Hammersmith Campus[Affiliation]"

Unlabelled: Remote polar regions offer unique opportunities and significant challenges for antimicrobial resistance research in a near-pristine environment. While core microbiology techniques continue to have an important role in supporting environmental research, the severe cold climate presents considerable challenges to laboratory research. We explore adaptations required for core bacteriology investigations in polar regions on an unsupported remote expedition c.

View Article and Find Full Text PDF
Article Synopsis
  • Tissue metabolomics provides valuable insights into tissue physiology and tumor characteristics, but obtaining this information is invasive, expensive, and can delay patient care.
  • Computed tomography (CT) is widely used but lacks detailed histological or prognostic information, and integrating metabolomic data with CT for improved classification and prognosis has not been extensively explored.
  • This study introduces a deep learning framework (TMR-CT) that combines CT images with metabolite data, achieving effective histology classification and prognosis in lung cancer patients, outperforming traditional methods and offering a non-invasive alternative to conventional tissue analysis.
View Article and Find Full Text PDF

Background: Unexplained infertility accounts for 25% of infertility causes in the UK. Active intervention methods, such as intrauterine insemination (IUI) or in vitro fertilisation (IVF), are often sought. Despite the National Institute for Health and Care Excellence (NICE) recommending IVF for unexplained infertility, this recommendation has generated an ongoing debate, with few fertility clinics discontinuing the use of IUI as the first-line management of choice.

View Article and Find Full Text PDF

Objectives: The novel CT-TDV scoring system, identifying T3 + disease; the presence/absence of tumour deposits and EMVI has been shown to be superior in predicting prognosis when compared to the CT-TNM staging system in the evaluation of colon cancer. Reproducibility of this scoring system between specialist GI radiologists has not been assessed previously. The aim of this study was to assess the inter-rater agreement of gastrointestinal radiologists in assessing the novel pre-operative CT-TDV scoring of patients with potentially curable right-sided colon cancer.

View Article and Find Full Text PDF

In synthetic biology, biosensors are routinely coupled with a gene expression system for detecting small molecules and physical signals. We reveal a fluorescent complex, based on the interaction of an coli double bond reductase (CurA), as a detection unit with its substrate curcumin-we call this a direct protein (DiPro) biosensor. Using a cell-free synthetic biology approach, we use the CurA DiPro biosensor to fine tune 10 reaction parameters (cofactor, substrate, and enzyme levels) for cell-free curcumin biosynthesis, assisted through acoustic liquid handling robotics.

View Article and Find Full Text PDF

Severe orthostatic hypotension and weight loss associated with cancer therapy.

Br J Cardiol

September 2021

Professor of Clinical Pharmacology Imperial College London - Hammersmith Campus, Imperial College Translational and Experimental Medicine Building (ICTEM), Third Floor - National Heart and Lung Institute (NHLI), Du Cane Road, London, W12 0NN.

Two cases of orthostatic hypotension associated with weight loss following cancer treatment are described. Conventional treatments for orthostatic hypotension proved ineffective. A hypothesis of association with skeletal muscle wasting is discussed.

View Article and Find Full Text PDF

Background: Cardiovascular prevention and rehabilitation programmes (CVPRP) are a preventive tool, which can reverse unhealthy behaviours and improve risk factor management. They have been successfully implemented in a variety of settings in patients with coronary heart disease (CHD).

Objective: The objective of this study is to evaluate an interdisciplinary and nurse-led cardiovascular prevention and rehabilitation programme in patients with coronary heart disease.

View Article and Find Full Text PDF

Evidence-Based Tools for Dietary Assessments in Nutrition Epidemiology Studies for Dementia Prevention.

J Prev Alzheimers Dis

May 2022

Prof Gary Frost, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London Hammersmith Campus, Commonwealth Building, Du Cane Road, London W12 ONN, United Kingdom, Tel: +44 (0)20 7594 0959. Fax: +44 (0208383 8320, Email :

Increasing evidence proposes diet as a notable modifiable factor and viable target for the reduction of Alzheimer's Disease risk and age-related cognitive decline. However, assessment of dietary exposures is challenged by dietary capture methods that are prone to misreporting and measurement errors. The utility of -omics technologies for the evaluation of dietary exposures has the potential to improve reliability and offer new insights to pre-disease indicators and preventive targets in cognitive aging and dementia.

View Article and Find Full Text PDF

(1) Background: The intra-tumoural heterogeneity (ITH) of hepatocellular carcinoma (HCC) and its microenvironment (TME) across primary and secondary disease is poorly characterised. (2) Methods: Intra-tumoural (IT) and peri-tumoural (PT) staining of matched primary and secondary samples was conducted to evaluate the distribution of CD4+/FOXP3+ and CD8+/PD1+ T-cells. Samples underwent PD-L1/2 immunostaining, tumour mutational burden (TMB) evaluation, and high-resolution T-cell receptor (TCR) sequencing to derive T-cell clonality and targeted transcriptomics.

View Article and Find Full Text PDF

Background: Coronary heart disease (CHD) persists as the leading cause of death worldwide. Cardiovascular prevention and rehabilitation (CVPR) has an interdisciplinary focus, and includes not only in physiological components, but it also addresses psycho-social factors.

Methods: The study analysed the Spanish psycho-social data collected during the EUROACTION study.

View Article and Find Full Text PDF

Hematoma Resolution In Vivo Is Directed by Activating Transcription Factor 1.

Circ Res

September 2020

From the National Heart and Lung Institute (A.S., Y.H., E.W., E.R.H.W., L.C., J.C.M., D.O.H., J.J.B.), Imperial College London Hammersmith Campus.

Rationale: The efficient resolution of tissue hemorrhage is an important homeostatic function. In human macrophages in vitro, heme activates an AMPK (AMP-activated protein kinase)/ATF1 (activating transcription factor-1) pathway that directs Mhem macrophages through coregulation of HO-1 (heme oxygenase-1; ) and lipid homeostasis genes.

Objective: We asked whether this pathway had an in vivo role in mice.

View Article and Find Full Text PDF

Background: Cardiovascular prevention and rehabilitation programmes (CVPRP) are an established model of care designed to improve risk factor management. They have been successfully implemented in a variety of settings, in patients with coronary heart disease (CHD).

Objective: To assess the long term impact of a nurse-coordinated, multidisciplinary, CVPRP in patients with CHD in the reduction of lipid profile and medication prescription in clinical practice.

View Article and Find Full Text PDF

Antibiotic therapy and outcome from immune-checkpoint inhibitors.

J Immunother Cancer

November 2019

National Centre for HIV Malignancy, Department of Oncology, Chelsea & Westminster Hospital, Fulham Road, London, SW10 9NH, UK.

Sensitivity to immune checkpoint inhibitor (ICPI) therapy is governed by a complex interplay of tumor and host-related determinants. Epidemiological studies have highlighted that exposure to antibiotic therapy influences the probability of response to ICPI and predict for shorter patient survival across malignancies. Whilst a number of studies have reproducibly documented the detrimental effect of broad-spectrum antibiotics, the immune-biologic mechanisms underlying the association with outcome are poorly understood.

View Article and Find Full Text PDF

Diffusion-weighted MRI in Advanced Epithelial Ovarian Cancer: Apparent Diffusion Coefficient as a Response Marker.

Radiology

November 2019

From the Cancer Research UK Cancer Imaging Centre, Division of Radiation Therapy and Imaging, The Institute of Cancer Research, London, England (J.M.W., J.C.W., E.P., D.J.C., N.M.d.S.); MRI Unit, Institute of Cancer Research and Royal Marsden Hospital, Royal Marsden NHS Foundation Trust, Downs Road, Sutton SM2 5PT, England (J.M.W., J.C.W., E.P., D.J.C., N.M.d.S.); Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, England (D.D., E.H.); Mount Vernon Cancer Centre, Mount Vernon Hospital, Northwood, England (M.H.); Department of Radiology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, England (S.F., A.N.P.); Cancer Research UK Cambridge Institute, Cambridge, England (J.D.B.); Addenbrooke's Hospital, Cambridge, England (J.D.B.); Department of Oncology, University of Cambridge, Cambridge, England (J.D.B.); Department of Gynaecological Oncology, Abertawe Bro Morgannwg Health Board, Morriston Hospital, Swansea, Wales (K.L.S.); Imaging Department, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, England (R.A.Q.); Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, England (N.J.T.); Imperial College London Hammersmith Campus, London, England (H.G.); Clinical Discovery Unit, Early Clinical Development, IMED Biotech Unit, Astrazeneca, Cambridge, England (H.G.); Department of Radiology, Abertawe Bro Morgannwg Health Board, Morriston Hospital, Swansea, Wales (L.M.); and Gynaecology Unit, Royal Marsden NHS Foundation Trust, Sutton, England (S.B.).

Background Treatment of advanced epithelial ovarian cancer results in a relapse rate of 75%. Early markers of response would enable optimization of management and improved outcome in both primary and recurrent disease. Purpose To assess the apparent diffusion coefficient (ADC), derived from diffusion-weighted MRI, as an indicator of response, progression-free survival (PFS), and overall survival.

View Article and Find Full Text PDF

Multi-cellularity in cardiac tissue engineering, how close are we to native heart tissue?

J Muscle Res Cell Motil

June 2019

National Heart and Lung Institute, Imperial College London Hammersmith Campus, Imperial Centre for Translational and Experimental Medicine, Du Cane Road, London, W12 0NN, UK.

Tissue engineering is a complex field where the elements of biology and engineering are combined in an attempt to recapitulate the native environment of the body. Tissue engineering has shown one thing categorically; that the human body is extremely complex and it is truly a difficult task to generate this in the lab. There have been varied attempts at trying to generate a model for the heart with numerous cell types and different scaffolds or materials.

View Article and Find Full Text PDF

Introduction: The 'Use of a Multi-drug Pill in Reducing cardiovascular Events' (UMPIRE) trial was a randomised controlled clinical trial evaluating the impact of a polypill strategy on adherence to indicated medication in a population with established cardiovascular disease (CVD) of or at high risk thereof. The aim of Researching the UMPIRE Processes for Economic Evaluation in the National Health Service (RUPEE NHS) is to estimate the potential health economic impact of a polypill strategy for CVD prevention within the NHS using UMPIRE trial and other relevant data. This paper describes the design of a modelled economic evaluation of the impact of increased adherence to the polypill versus usual care among the UK UMPIRE participants.

View Article and Find Full Text PDF

Reply.

J Hypertens

November 2017

aDepartment of Cardiology and Clinical Research, Inselspital Bern, University of Bern, Bern, Switzerland bMount Sinai Icahn School of Medicine, New York, New York, USA cJagiellonian University Krakow, Kraków, Poland dDepartment of Clinical and Experimental Sciences, Clinica Medica, University of Brescia, Brescia, Italy eService de Néphrologie et Hypertension, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland fDepartment of Biomedical Sciences, Pacific Northwest University of Health Sciences, Yakima, Washington gHeart Disease Prevention Program, Division of Cardiology, Department of Medicine, C240 Medical Sciences, University of California, Irvine, California, USA hDepartment of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland iDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine,Tochigi, Japan jDepartment of Cardiology, University of Oslo, Ullevaal Hospital, Oslo, Norway kCardiovascular Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA lDepartment of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR 970, University Paris Descartes, Paris, France mHypertension Unit, University of Ottawa Heart Institute, Ottawa, Ontario, Canada nDepartment of Medicine, Maastricht University Medical Center, Maastricht University, Maastricht, the Netherlands oDepartment of Heart Diseases, University of Bergen, Haukeland Hospital, Bergen, Norway pUniversity of Milano-Bicocca qIRCCS Istituto Auxologico Italiano, Milan, Italy rDepartment of Hypertension and Diabetology, Medical University of Gdańsk, Gdańsk, Poland sHypertension and Cardiovascular Research Clinic, Veterans Affairs and Georgetown University Medical Centers, Washington, District of Columbia, USA tDepartment of Cardiovascular, Neural and Metabolic Sciences, Ospedale S. Luca IRCCS Istituto Auxologico Italiano uDepartment of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy vImperial Clinical Trials Unit, Imperial College London, London, UK wHospital Clinico Unviersitario de Valencia, Valencia xDepartment of Nephrology, Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain yDepartment of Medicine, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Québec, Canada zDepartment of Nephrology and Hypertension, Friedrich-Alexander- University Erlangen-Nürnberg (FAU), Erlangen, Germany aaDivision of Nephrology and Hypertension, Department of Medicine bbAmerican Society of Hypertension, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA ccInternational Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London - Hammersmith Campus, London, UK ddDiabetes and Cardiovascular Center, University of Missouri School of Medicine eeDepartment Service, Harry S Truman Memorial Veterans Hospital ffDepartment of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, Missouri, USA ggUniversity of Leuven, Leuven, Belgium hhDepartment of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China iiSUNY Downstate Medical Center, Brooklyn, New York, USA jjUniversity College London and NIHR University College London Hospitals Biomedical Research Centre, University College London, London, UK.

View Article and Find Full Text PDF

Expertise: no longer a sine qua non for guideline authors?

J Hypertens

August 2017

aDepartment of Cardiology and Clinical Research, Inselspital Bern, University of Bern, Bern, Switzerland bMount Sinai Icahn School of Medicine, New York, New York, USA cJagiellonian University Krakow, Kraków, Poland dDepartment of Clinical and Experimental Sciences, Clinica Medica, University of Brescia, Brescia, Italy eService de Néphrologie et Hypertension, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland fDepartment of Biomedical Sciences, Pacific Northwest University of Health Sciences, Yakima, Washington gHeart Disease Prevention Program, Division of Cardiology, Department of Medicine, C240 Medical Sciences, University of California, Irvine, California, USA hDepartment of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland iDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan jDepartment of Cardiology, University of Oslo, Ullevaal Hospital, Oslo, Norway kCardiovascular Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA lDepartment of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR 970, University Paris Descartes, Paris, France mHypertension Unit, University of Ottawa Heart Institute, Ottawa, Ontario, Canada nDepartment of Heart Diseases, University of Bergen, Haukeland Hospital, Bergen, Norway oUniversity of Milano-Bicocca pIRCCS Istituto Auxologico Italiano, Milan, Italy qDepartment of Hypertension and Diabetology, Medical University of Gdansk, Gdańsk, Poland rHypertension and Cardiovascular Research Clinic, Veterans Affairs and Georgetown University Medical Centers, Washington, District of Columbia, USA sDepartment of Cardiovascular, Neural and Metabolic Sciences, Ospedale S. Luca IRCCS Istituto Auxologico Italiano tDepartment of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy uImperial Clinical Trials Unit, Imperial College London, London, UK vHospital Clinico Unviersitario de Valencia, Valencia wDepartment of Nephrology, Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain xDepartment of Medicine, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Québec, Canada yDepartment of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany zDivision of Nephrology and Hypertension, Department of Medicine aaAmerican Society of Hypertension, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA bbInternational Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London - Hammersmith Campus, London, UK ccDiabetes and Cardiovascular Center, University of Missouri School of Medicine ddDepartment Service, Harry S Truman Memorial Veterans Hospital eeDepartment of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, Missouri, USA ffUniversity of Leuven, Leuven, Belgium ggDepartment of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China hhSUNY Downstate Medical Center, Brooklyn, New York, USA iiUniversity College London and NIHR University College London Hospitals Biomedical Research Centre, University College London, London, UK jjDepartment of Medicine, Masstricht University Medical Center, Maastricht University, Maastricht, the Netherlands.

: Several sets of guidelines have been published recently and more are in the works. The very recent American College of Physicians/American Academy of Family Practitioners guidelines were put together by a set of authors and consultants without any expertise in the topic under discussion, that is, hypertension. Although we are not maintaining that all guidelines should be written exclusively by experts, complete lack of expertise among guideline authors is not acceptable.

View Article and Find Full Text PDF

Expertise: No Longer a Sine Qua Non for Guideline Authors?

Hypertension

August 2017

From the Department of Cardiology and Clinical Research, Inselspital Bern, University of Bern, Switzerland (F.H.M., L.H., S.F.R.); Mount Sinai Icahn School of Medicine, New York, NY (F.H.M.); Jagiellonian University Krakow, Poland (F.H.M.); Department of Clinical and Experimental Sciences, Clinica Medica, University of Brescia, Italy (E.A.R.); Service de Néphrologie et Hypertension, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland (M.B.); Department of Biomedical Sciences, Pacific Northwest University of Health Sciences, Yakima, WA (W.J.E.); Heart Disease Prevention Program, Division of Cardiology, Department of Medicine, C240 Medical Sciences, University of California, Irvine (S.S.F.); Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland (T.G.); Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan (K.K.); Department of Cardiology, University of Oslo, Ullevaal Hospital, Norway (S.E.K.); Cardiovascular Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (J.B.K.); Departments of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR 970, University Paris Descartes, France (S.L.); Hypertension Unit, University of Ottawa Heart Institute, ON, Canada (F.H.L.); Department of Heart Diseases, University of Bergen, Haukeland Hospital, Norway (P.L.-J.); University of Milano-Bicocca, IRCCS Istituto Auxologico Italiano, Italy (G.M.); Department of Hypertension and Diabetology, Medical University of Gdansk, Poland (K.N.); Hypertension and Cardiovascular Research Clinic, Veterans Affairs and Georgetown University Medical Centers, Washington DC (V.P.); Department of Cardiovascular, Neural and Metabolic Sciences, Ospedale S. Luca IRCCS Istituto Auxologico Italiano, Milan; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy (G.P.); Imperial Clinical Trials Unit, Imperial College London, United Kingdom (N.P.); Hospital Clinico Unviersitario de Valencia, Spain (J.R.); Department of Nephrology, Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain (L.M.R.); Lady Davis Institute for Medical Research and Department of Medicine, Jewish General Hospital, McGill University, Montreal, QC, Canada (E.L.S.); Department of Nephrology and Hypertension, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Germany (R.E.S.); Division of Nephrology and Hypertension, Department of Medicine, and American Society of Hypertension, Drexel University College of Medicine, Philadelphia, PA (A.B.S.); International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London-Hammersmith Campus, United Kingdom (P.S.); Diabetes and Cardiovascular Center, University of Missouri School of Medicine, Columbia; Research Service, Harry S. Truman Memorial Veterans Hospital, Research Service, Columbia; Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia (J.R.S.); University of Leuven, Belgium (J.A.S.); Department of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (J.W.); SUNY Downstate Medical Center, Brooklyn, NY (M.W.); and University College London and NIHR University College London Hospitals Biomedical Research Centre, University College London, UK (B.W.).

View Article and Find Full Text PDF

True Resistant Hypertension Following Observed Drug Ingestion: A Systematic Evaluation.

J Clin Hypertens (Greenwich)

March 2017

International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London - Hammersmith Campus, London, UK.

The authors investigated the role of poor drug adherence in treatment-resistant hypertension following observed drug ingestion in 102 patients. Median blood pressures (BPs) were 170/91 mm Hg at referral, 153/84 mm Hg prior to, and 142/79 mm Hg during a 4- to 6-hour period after drug ingestion. Median daytime ambulatory BP monitoring (ABPM) over the following 24 hours was 142/80 mm Hg.

View Article and Find Full Text PDF

Lipid rafts are dynamic membrane microdomains that orchestrate molecular interactions and are implicated in cancer development. To understand the functions of lipid rafts in cancer, we performed an integrated analysis of quantitative lipid raft proteomics data sets modeling progression in breast cancer, melanoma, and renal cell carcinoma. This analysis revealed that cancer development is associated with increased membrane raft-cytoskeleton interactions, with ∼40% of elevated lipid raft proteins being cytoskeletal components.

View Article and Find Full Text PDF

Background: The complement system is a key component of innate immunity implicated in the neutralization and clearance of invading pathogens. Dextran coated superparamagnetic iron oxide (SPIO) nanoparticle is a promising magnetic resonance imaging (MRI) contrast agent. However, dextran SPIO has been associated with significant number of complement-related side effects in patients and some agents have been discontinued from clinical use (e.

View Article and Find Full Text PDF

Background: Adequate organ function and good performance status (PS) are common eligibility criteria for phase I trials. As inflammation is pathogenic and prognostic in cancer we investigated the prognostic performance of inflammation-based indices including the neutrophil (NLR) and platelet to lymphocyte ratio (PLR).

Methods: We studied inflammatory scores in 118 unselected referrals.

View Article and Find Full Text PDF

Unlabelled: Epithelial ovarian cancer is the leading cause of death from gynecologic malignancy, and its molecular basis is poorly understood. We previously demonstrated that opioid binding protein cell adhesion molecule (OPCML) was frequently epigenetically inactivated in epithelial ovarian cancers, with tumor suppressor function in vitro and in vivo. Here, we further show the clinical relevance of OPCML and demonstrate that OPCML functions by a novel mechanism in epithelial ovarian cancer cell lines and normal ovarian surface epithelial cells by regulating a specific repertoire of receptor tyrosine kinases: EPHA2, FGFR1, FGFR3, HER2, and HER4.

View Article and Find Full Text PDF